|
Market Closed -
NSE India S.E.
07:05:06 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 224.25 INR | -7.40% |
|
+33.27% | +5.12% |
Company Valuation: Arvee Laboratories (India) Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 610.5 | 1,253 | 969.8 | 1,580 | 1,565 | 1,475 |
| Change | - | 105.23% | -22.6% | 62.95% | -0.98% | -5.73% |
| Enterprise Value (EV) 1 | 612.9 | 1,238 | 970.8 | 1,572 | 1,526 | 1,454 |
| Change | - | 101.99% | -21.58% | 61.88% | -2.9% | -4.75% |
| P/E | 22.8x | 48.7x | 23.5x | 151x | 72.9x | 58.5x |
| PBR | 2.85x | 5.23x | 3.46x | 5.43x | 5.01x | 4.37x |
| PEG | - | -12.59x | 0.4x | -2x | 1x | 3.3x |
| Capitalization / Revenue | 1.29x | 3.11x | 1.58x | 5.21x | 4.07x | 4.68x |
| EV / Revenue | 1.29x | 3.07x | 1.58x | 5.18x | 3.96x | 4.61x |
| EV / EBITDA | 10.1x | 21.8x | 13.3x | 53.7x | 42.3x | 45.6x |
| EV / EBIT | 16.7x | 36.9x | 18.7x | 109x | 62x | 73.5x |
| EV / FCF | -53.5x | 161x | -361x | 44.3x | -69.3x | -35.6x |
| FCF Yield | -1.87% | 0.62% | -0.28% | 2.26% | -1.44% | -2.81% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 2.43 | 2.336 | 3.738 | 0.95 | 1.949 | 2.29 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 473.8 | 403.3 | 613.5 | 303.5 | 384.9 | 315.1 |
| EBITDA 1 | 60.6 | 56.68 | 72.73 | 29.29 | 36.11 | 31.91 |
| EBIT 1 | 36.62 | 33.56 | 52.02 | 14.39 | 24.62 | 19.77 |
| Net income 1 | 26.77 | 25.74 | 41.19 | 10.52 | 21.47 | 25.26 |
| Net Debt 1 | 2.4 | -14.98 | 1.083 | -8.655 | -38.73 | -21.57 |
| Reference price 2 | 55.40 | 113.70 | 88.00 | 143.40 | 141.99 | 133.86 |
| Nbr of stocks (in thousands) | 11,020 | 11,020 | 11,020 | 11,020 | 11,020 | 11,020 |
| Announcement Date | 8/24/21 | 5/26/22 | 8/25/23 | 9/3/24 | 8/30/25 | 9/3/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 27.86M | ||
| 19.33x | 3.42x | 9.7x | 2.05% | 68.64B | ||
| 12.33x | 0.93x | 7.8x | 4.37% | 51.18B | ||
| 56.59x | 9.07x | 38.65x | 0.96% | 16.87B | ||
| 12.9x | 0.86x | 6.01x | 2.82% | 13.6B | ||
| 11.88x | 0.74x | 4.79x | 2.83% | 10.2B | ||
| 15.42x | 0.7x | 7.6x | 3.2% | 9.74B | ||
| 36.64x | 1.68x | 8.86x | 2.06% | 9.15B | ||
| 4.69x | 0.67x | 2.78x | 4.69% | 8.94B | ||
| 31.56x | 4.32x | 18.49x | 0.37% | 7.86B | ||
| Average | 22.37x | 2.49x | 11.63x | 2.59% | 19.62B | |
| Weighted average by Cap. | 20.31x | 2.64x | 11.07x | 2.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ARVEE Stock
- Valuation Arvee Laboratories (India) Ltd.
Select your edition
All financial news and data tailored to specific country editions
















